Human papillomavirus 16 and 18 DNA can solely induce oncogenic transformation of mammalian cells in primary culture

References

• Durst M, Gissmann L, Ikenberg H, Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983; 80: 3812–5
   PubMed Web of Science ®Google Scholar
• Campion M J, McCance D J, Cuzick J, Singer A. Progressive potential of mild cervical atypia: prospective cytological, colposcopic and virological study. Lancet 1986; ii: 237
   Google Scholar
• Yasumoto S, Burkhardt A L, Doniger J, DiPaolo J A. Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells. J Virol 1986; 57: 572–7
   PubMedGoogle Scholar
• Tsunokawa Y, Takebe N, Kasamatsu T, Terada M, Sugimura T. Transforming activity of human papillomavirus type 16 DNA sequences in a cervical cancer. Proc Natl Acad Sci USA 1986; 83: 2200–3
   PubMedGoogle Scholar
• Matlashewski G, Osborn K, Murray A, Banks L, Crawford L. Cancer cells. Papillomaviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1987; Vol 5: 195–9
   Google Scholar
• Iwasaka T, Yokoyama M, Hayashi Y, Sugimori H. Combined herpes simplex virus type 2 and human papillomavirus type 16 or 18 deoxyribonucleic acid leads to oncogenic transformation. Am J Obstet Gynecol 1988; 159: 1251–5
   PubMed Web of Science ®Google Scholar
• Durst M, Dzarlieva-Petrusevska R T, Boukamp P, Fusenig E, Gissmann L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1987; 1: 251–6
   PubMed Web of Science ®Google Scholar
• Pirisi L, Yasumoto S, Feller M, Doniger J, DiPaolo J A. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 1987; 61: 1061–6
   PubMed Web of Science ®Google Scholar
• Kanda T, Watanabe S, Yoshiike K. Immortalization of primary rat cells by human papillomavirus type 16 subgeno-mic DNA fragments controlled by SV40 promoter. Virol 1988; 165: 321–5
   PubMedGoogle Scholar
• Schlegel R, Phelps W C, Zhang Y L, Barbosa M. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J 1988; 7: 3181–7
   PubMed Web of Science ®Google Scholar
• Woodworth C D, Bowden P E, Doniger J, Pirisi L, Barnes W, Lancaster W D, DiPaolo J A. Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA. Cancer Res 1988; 48: 4620–8
   PubMed Web of Science ®Google Scholar
• Munger K, Phelps W C, Bubb V, Howley P M, Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989; 63: 4417–21
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Iwasaka T, Smith C C, Aurelian L, Lewis G K, Ts'o P OP. Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene product. Proc Natl Acad Sci USA 1985; 82: 8493–7
   Google Scholar
• De Villiers E-M, Gissmann L, Hausen H. Molecular cloning of viral DNA from human genital warts. J Virol 1981; 40: 932–5
   PubMed Web of Science ®Google Scholar
• Gissmann L, Diehl V, Schultz-Loulon H J, zur Hausen H. Molecular cloning and characterization of human papil-lomavirus DNA derived from a laryngeal papilloma. J Virol 1982; 44: 393–400
   PubMed Web of Science ®Google Scholar
• Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983; 80: 3812–5
   PubMed Web of Science ®Google Scholar
• Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Sche-Urlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984; 3: 1151–7
   PubMed Web of Science ®Google Scholar
• Storey A, Pirn D, Murray A, Osborn K, Banks L, Crawford L. Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J 1988; 7: 1815–20
   PubMed Web of Science ®Google Scholar
• Woodworth C D, Doniger J, DiPaolo J A. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol 1989; 63: 159–64
   PubMed Web of Science ®Google Scholar
• Chesters P M, McCance D J. Human papillomavirus types 6 and 16 in cooperation with Ha-ras transform secondary rat embryo fibroblasts. J Gen Virol 1989; 70: 353–65
   Google Scholar
• Lorincz A T, Temple G F, Kurman R J, Jenson A B, Lancaster W D. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst 1987; 79: 671–7
   PubMed Web of Science ®Google Scholar
• Reid R, Greenberg M, Jensen A B, Husaim M, Willett J, Daoud Y, Temple G, Stanhope C R, Sherman A I, Phibbs G D, Lorincz A T. Sexually transmitted papillomaviral infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol 1987; 156: 212–22
   PubMed Web of Science ®Google Scholar
• Fuchs P, Girardi F, Pfister H. Human papillomavirus DNA in normal, metaplastic, preneoplastic, and neoplastic epi-thelia of the cervix uteri. Int J Cancer 1988; 41: 41–5
   PubMed Web of Science ®Google Scholar
• Syrjaenen K, Saarikoski S, Vaeyrynen M, Syrjaenen S, Saastamoinen J, Castren O. Factors associated with clinical behaviour of cervical human papillomavirus infections during a long-term prospective follow-up. The CERVIX & lfgt 1989; 7: 131–113
   Google Scholar
• zur Hausen H. Genital papillomavirus infections. Prog Med Virol 1985; 32: 15–21
   PubMedGoogle Scholar
• Pecoraro G, Lee M, Morgan D, Defendi V. Evolution of in vitro transformation and tumorigenesis of HPV 16 and HPV 18 immortalized primary cervical epithelial cells. Am J Pathol 1991; 138: 1–8
   PubMed Web of Science ®Google Scholar
• Durst M, Croce C M, Gissmann L, Schwarz E, Huebner K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 1987; 84: 1070–11
   PubMed Web of Science ®Google Scholar
• Okadiz R, Sauceda R, Cruz M, Graef C A, Gariglio P. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. Cancer Res 1987; 47: 4173–7
   Google Scholar
• Riou G, Barrois M, Le M G, George M, Le Doussal V, Haie C. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet 1987; i: 761
   Google Scholar
• Baker W, Hatch K D, Shingleton H M. Amplification of the c-myc proto-oncogene in cervical carcinoma. J Surg Oncol 1988; 39: 225–8
   PubMed Web of Science ®Google Scholar
• Riou G, Barrois M, Sheng Z-M, Duvillard P, Lhomme C. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene 1988; 3: 329–33
   PubMedGoogle Scholar
• Sagae S, Kuzumaki N, Hisada T, Mugikura Y, Kudo R, Hashimoto M. Ras oncogene expression and prognosis of invasive squamous cell carcinomas of the uterine cervix. Cancer 1989; 63: 1577–82
   Google Scholar
• Schwarz L C, Gingras M C, Goldberg G, Greenberg A H, Wright J A. Loss of growth factor dependence and conversion of transforming growth factor-P inhibition to stimulation in metastatic H-ras transformed murine fibroblasts. Cancer Res 1988; 48: 6999–7003
   PubMedGoogle Scholar
• Schwarz L C, Wright J A, Gingras M C, Kondaiah P, Daniel-Pour D, Pimentel M, Sporn M B, Greenberg A H. Aberrant TGF-beta production and regulation in metastatic malignancy. Growth Factors 1990; 3: 115–27
   PubMedGoogle Scholar